Metabolites generated in the kynurenine pathway, as well as the expression of IDO, have been implicated in modulating the progression of atherosclerosis, although the overall effects (atheroprotection or progression) are not yet fully understood. The gene discussed is IDO1; the disease is atherosclerosis.